Recombinant TSH and Lithium Overcomes Amiodarone-Induced Low Radioiodine Uptake in a Thyrotoxic Female | Zendy

Nestor Eric Ruiz Laplano | Zendy; Leilani B Mercado-Asis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Recombinant TSH and Lithium Overcomes Amiodarone-Induced Low Radioiodine Uptake in a Thyrotoxic Female

Author(s) -

Nestor Eric Ruiz Laplano,

Leilani B Mercado-Asis

Publication year - 2012

Publication title -

international journal of endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.652

H-Index - 23

eISSN - 1726-9148

pISSN - 1726-913X

DOI - 10.5812/ijem.5406

Subject(s) - medicine , amiodarone , endocrinology , lithium (medication) , recombinant dna , thyroid dysfunction , thyroid , atrial fibrillation , biochemistry , chemistry , gene

Recombinant human thyroid-stimulating hormone(rhTSH) increases radioactive iodine uptake(RAIU) in selected populations, while lithium is used as an adjunct to radioactive iodine (RAI) therapy in Graves' disease with low RAIU. In this report, both drugs used in combination, overcame low iodine-131 uptake in a Graves' patient.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research